Cargando…
Structure-Based Drug Discovery for Prion Disease Using a Novel Binding Simulation
The accumulation of abnormal prion protein (PrP(Sc)) converted from the normal cellular isoform of PrP (PrP(C)) is assumed to induce pathogenesis in prion diseases. Therefore, drug discovery studies for these diseases have focused on the protein conversion process. We used a structure-based drug dis...
Autores principales: | Ishibashi, Daisuke, Nakagaki, Takehiro, Ishikawa, Takeshi, Atarashi, Ryuichiro, Watanabe, Ken, Cruz, Felipe A., Hamada, Tsuyoshi, Nishida, Noriyuki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4972544/ https://www.ncbi.nlm.nih.gov/pubmed/27333028 http://dx.doi.org/10.1016/j.ebiom.2016.06.010 |
Ejemplares similares
-
Increased expression of p62/SQSTM1 in prion diseases and its association with pathogenic prion protein
por: Homma, Takujiro, et al.
Publicado: (2014) -
Ubiquitin-specific protease 14 modulates degradation of cellular prion protein
por: Homma, Takujiro, et al.
Publicado: (2015) -
Type I interferon protects neurons from prions in in vivo models
por: Ishibashi, Daisuke, et al.
Publicado: (2019) -
Strain-Dependent Effect of Macroautophagy on Abnormally Folded Prion Protein Degradation in Infected Neuronal Cells
por: Ishibashi, Daisuke, et al.
Publicado: (2015) -
Administration of FK506 from Late Stage of Disease Prolongs Survival of Human Prion-Inoculated Mice
por: Nakagaki, Takehiro, et al.
Publicado: (2020)